| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/15/2011 | EP2332574A1 HCV NS3/4A Sequences |
| 06/15/2011 | EP2332573A1 Chimeric alphavirus replicon particles |
| 06/15/2011 | EP2332572A1 Nucleic acid vaccines for prevention of Flavivirus |
| 06/15/2011 | EP2332565A1 Low dose methods for treating disorders in which TNFalpha activity is detrimental |
| 06/15/2011 | EP2332564A1 Matrix-free osteogenic devices, implants and methods thereof |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332408A1 Treating neurological disorders |
| 06/15/2011 | EP2331971A1 Estrogen and anti-estrogen marker genes |
| 06/15/2011 | EP2331697A2 Methods concerning ppar delta and antagonists thereof |
| 06/15/2011 | EP2331693A2 An expression vector and a method thereof |
| 06/15/2011 | EP2331580A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 06/15/2011 | EP2331569A1 Recombinantly produced human factor viii and ix |
| 06/15/2011 | EP2331568A2 Treating inflammatory conditions |
| 06/15/2011 | EP2331567A1 Peptidomimetic macrocycles |
| 06/15/2011 | EP2331566A1 Method and compositions for enhanced anti-tumor effector functioning of t cells |
| 06/15/2011 | EP2331565A2 Hiv-1 envelope polypeptides for hiv vaccine |
| 06/15/2011 | EP2331564A2 Methods of treating inflammation |
| 06/15/2011 | EP2331563A1 Peptidic and peptidomimetic compounds for regulating autophagy |
| 06/15/2011 | EP2331124A1 T-cell antigen peptide from allergen for stimulation of il-10 production |
| 06/15/2011 | EP2331121A1 Vaccine comprising protein nmbo964 from meisseria meningitidis |
| 06/15/2011 | EP2331117A1 Vaccines containing canine parvovirus genetic variants |
| 06/15/2011 | EP2046830B1 Csf3r polypeptides and uses thereof |
| 06/15/2011 | EP1928901B1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 06/15/2011 | EP1878745B1 Humanin receptor or humanin-like polypeptide receptor |
| 06/15/2011 | EP1824881B1 Tgr3-like protein receptor |
| 06/15/2011 | EP1751189B1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 06/15/2011 | EP1651765B1 Novel photobacterium damselae nucleotide and amino acid sequences and uses thereof |
| 06/15/2011 | EP1616000B1 Expression of proteins in cord blood-derived endothelial cells |
| 06/15/2011 | EP1481061B1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 06/15/2011 | EP1476462B1 Novel fungal lipase |
| 06/15/2011 | EP1455809B1 Inhibitors of hepatitis c virus |
| 06/15/2011 | EP1417344B1 Zinc finger domain libraries |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1404710B1 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | EP0805822B2 Spray dried erythropoietin |
| 06/15/2011 | CN1954883B Method for stabilizing hemoglobin oxygen carrier sample |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1543503B Metalloproteinase inhibitors for wound healing |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099480A Plants having enhanced yield-related traits and a method for making the same |
| 06/15/2011 | CN102099479A Plante brassica comprenant un allele indehiscent mutant |
| 06/15/2011 | CN102099476A Compositions and methods for improving plants |
| 06/15/2011 | CN102099470A Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 06/15/2011 | CN102099460A Filamentous fungi with inactivated protease genes for altered protein production |
| 06/15/2011 | CN102099374A Methods and compositions for modulating angiogenesis and pericyte composition |
| 06/15/2011 | CN102099373A Multivalent fibronectin based scaffold domain proteins |
| 06/15/2011 | CN102099372A Anti-amyloid immunogenic compositions, methods and uses |
| 06/15/2011 | CN102099371A New bacteriophage adhesion proteins |
| 06/15/2011 | CN102099050A Orally administrable dosage forms comprising angiogenin and uses thereof |
| 06/15/2011 | CN102094043A Construction and application of recombinant pig chemotactic factor CXCL12 mammalian cell expression plasmid |
| 06/15/2011 | CN102094030A Pesticidal protein encoding gene Cry1Ab-Ma and expression vector and application thereof |
| 06/15/2011 | CN102094029A Method for preparing allophycocyanin tripolymer fluorescent protein |
| 06/15/2011 | CN102094028A Chinese rose RcLEA coding sequence and application thereof |
| 06/15/2011 | CN102094027A Rice blast resistance gene Pi7 and application thereof |
| 06/15/2011 | CN102094026A Protein HlpB gene capable of stimulating plant to perform allergic reaction |
| 06/15/2011 | CN102094025A Brassica napus AP2/ERF family transcription factor gene and preparation method thereof and application thereof |
| 06/15/2011 | CN102094024A Plutella xylostella cecropin gene, encoded protein, corresponding expression system and application |
| 06/15/2011 | CN102094023A Plutella xylostella gloverin gene and encoded protein, corresponding expression system and application |
| 06/15/2011 | CN102094006A Brassica napus ERF-B3 family transcription factor gene and preparation method thereof |
| 06/15/2011 | CN102094005A Antifreeze transcription factor derived from common wheat AP2/ERF family and preparation method and application thereof |
| 06/15/2011 | CN102093982A H9N2 subtype avian influenza virus strain and application thereof |
| 06/15/2011 | CN102093476A Preparation method of AI (Angiotensin I) immunogen |
| 06/15/2011 | CN102093475A Analogue of glucagon like peptide-1 |
| 06/15/2011 | CN102093474A Preparation method of chloramphenicol artificial immunogen |
| 06/15/2011 | CN102093473A Preparation method of bacteriostatic active protein of Sinonovacula constricta Lamarck epipsymbiosis strain |
| 06/15/2011 | CN102093472A Preparation method of antimicrobial active protein for echinus symbiotic bacterial strains |
| 06/15/2011 | CN101671345B Curcumol hapten and artificial antigen as well as preparation method thereof |
| 06/15/2011 | CN101649003B Method for extracting beta-hyskon, starch, protein and grease from oat |
| 06/15/2011 | CN101608182B Oncogene, recombinant protein derived therefrom, and uses thereof |
| 06/15/2011 | CN101392020B Musca domestic pupae natural antimicrobial peptide products and preparation method and use thereof |
| 06/15/2011 | CN101294188B Lactoferrin antimicrobial peptide, preparing method and uses thereof |
| 06/15/2011 | CN101195657B Type I cell factor receptor sample molecule, encoding gene and application thereof |
| 06/15/2011 | CN101166545B Glp-1 pegylated compounds |
| 06/15/2011 | CN101144093B Recombination expression carrier and method for soluble expressing human I-type metallothionin |
| 06/15/2011 | CN101144077B Method for preparing allophycocyanin fluorescence protein |
| 06/15/2011 | CN101010338B Muteins of fibroblast growth factor 21 |
| 06/14/2011 | US7960607 Plants having modified growth characteristics and a method for making the same |
| 06/14/2011 | US7960535 Recombinant lipidated PsaA protein, methods of preparation and use |
| 06/14/2011 | US7960533 Nucleic acids coding for adhesion factor of group B Streptococcus, adhesion factors of group B Streptococcus and further uses thereof |
| 06/14/2011 | US7960531 EG-VEGF nucleic acids and polypeptides and methods of use |
| 06/14/2011 | US7960530 Fluorescent protein |
| 06/14/2011 | US7960527 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 06/14/2011 | US7960524 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 06/14/2011 | US7960514 IL-7 fusion proteins |
| 06/14/2011 | US7960509 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials |
| 06/14/2011 | US7960508 A peptide fragment containing selenocysteine has a lowered toxicity than selenocystine, exhibits a cytotoxicity-inhibitory activity; screening a drug having cytotoxicity-inhibitory activity by utilizing a cellular sudden death phenomenon in a cell culture system; glutathione peroxidase activity |
| 06/14/2011 | US7960507 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 06/14/2011 | US7960504 Inhibitors of HIV membrane fusion |
| 06/14/2011 | US7960361 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 06/14/2011 | US7960345 Angiogenesis inhibitor comprising meteorin as an active ingredient |
| 06/14/2011 | US7960340 Cystine knot molecules |
| 06/14/2011 | US7960312 Method and agent for immobilizing protein via protein bound to silicon oxide-containing substance |
| 06/14/2011 | US7960311 Methods employing combinatorial artificial receptors |
| 06/14/2011 | US7960182 Affinity adsorbents for Factor VIII and von Willebrand's Factor |
| 06/14/2011 | US7960140 Avidin mutants |
| 06/14/2011 | US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 06/14/2011 | US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception |
| 06/14/2011 | US7960123 Multimarker panel based on PIGF for diabetes types 1 and 2 |